• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新建立的失巢凋亡相关基因可预测肝细胞癌的预后。

Newly Established Anoikis-Associated Genes Predict the Prognosis of Hepatocellular Carcinoma.

作者信息

Li Yuyao, Li Er, Zheng Wenlan, Shi Jia, Yu Shihan, Zhang Xuemei, Zheng Liming, Du Wurong, Liu Hao, Feng Hai, Guo Jianfeng, Yu Zhuo

机构信息

Department of Liver Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.

Institute of Infectious Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.

出版信息

J Hepatocell Carcinoma. 2025 Sep 3;12:2017-2034. doi: 10.2147/JHC.S533398. eCollection 2025.

DOI:10.2147/JHC.S533398
PMID:40927650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12415389/
Abstract

OBJECTIVE

Anoikis is an anchorage-dependent programmed cell death implicated in multiple pathological processes of cancers; however, the prognostic value of anoikis-related genes (ANRGs) in hepatocellular carcinoma (HCC) remains unclear. Our study aims to develop an ANRGs-based prediction model to improve prognostic assessment in HCC patients.

METHODS

The RNA-seq profile was performed to estimate the expression of ANRGs in HCC patients. The univariate Cox regression and the least absolute shrinkage and selection operator (LASSO) Cox regression analysis were applied in the model construction to predict the prognosis in terms of differentially expressed ANRGs in the Cancer Genome Atlas (TCGA) training cohort. The TCGA test cohort and the International Cancer Genome Consortium (ICGC)-originated cohort were set to verify the predictive capacity. Nomogram was built on the basis of risk score (RS), gender, age, grade, and T_stage, with the hope of extending the predictive ability of ANRGs to evaluate the HCC prognosis. The expression of differentially expressed ANRGs was assessed in HCC cell lines and orthotopic tumor-bearing mice.

RESULTS

Six ANRGs ( and ) demonstrated the critical prognostic significance in HCC patients. The prognostic model on the basis of these ANRGs was capable of properly predicting 1-, 3-, and 5-year survivals. The Kaplan-Meier results displayed the increased death and decreased survival in the high-risk group. The acted as the independent factor for the survival evaluation. Our nomogram model was able to directly reflect the survival probabilities of each patient, which was confirmed through various validations. The transcription and translation of six ANRGs were significantly enhanced in HCC cell lines and tumor tissues.

CONCLUSION

Despite the lack of mechanistic validation, our anoikis-linked model serves as a promising tool for predicting HCC prognosis in clinical practice, and provides valuable insights into the decision of individualized therapeutic approaches.

摘要

目的

失巢凋亡是一种锚定依赖性程序性细胞死亡,与癌症的多种病理过程相关;然而,失巢凋亡相关基因(ANRGs)在肝细胞癌(HCC)中的预后价值仍不清楚。我们的研究旨在开发一种基于ANRGs的预测模型,以改善对HCC患者的预后评估。

方法

进行RNA测序分析以评估HCC患者中ANRGs的表达。单变量Cox回归和最小绝对收缩和选择算子(LASSO)Cox回归分析应用于模型构建,以根据癌症基因组图谱(TCGA)训练队列中差异表达的ANRGs预测预后。设置TCGA测试队列和国际癌症基因组联盟(ICGC)来源的队列以验证预测能力。基于风险评分(RS)、性别、年龄、分级和T分期构建列线图,希望扩展ANRGs的预测能力以评估HCC预后。在HCC细胞系和原位荷瘤小鼠中评估差异表达的ANRGs的表达。

结果

六个ANRGs(……此处原文缺失六个基因具体信息……)在HCC患者中显示出关键的预后意义。基于这些ANRGs的预后模型能够准确预测1年、3年和5年生存率。Kaplan-Meier结果显示高危组死亡增加、生存减少。……此处原文缺失具体因素信息……作为生存评估的独立因素。我们的列线图模型能够直接反映每位患者的生存概率,这通过各种验证得到证实。六个ANRGs的转录和翻译在HCC细胞系和肿瘤组织中显著增强。

结论

尽管缺乏机制验证,但我们的失巢凋亡相关模型是临床实践中预测HCC预后的有前景的工具,并为个体化治疗方法的决策提供了有价值的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/98f0505868e3/JHC-12-2017-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/93a8ef208d11/JHC-12-2017-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/6b844ace92f1/JHC-12-2017-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/3d33a16d208a/JHC-12-2017-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/27557c278287/JHC-12-2017-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/87d2c0d71b93/JHC-12-2017-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/ab9935d576e1/JHC-12-2017-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/9d64de8b5bbf/JHC-12-2017-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/642aef575a58/JHC-12-2017-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/98f0505868e3/JHC-12-2017-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/93a8ef208d11/JHC-12-2017-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/6b844ace92f1/JHC-12-2017-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/3d33a16d208a/JHC-12-2017-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/27557c278287/JHC-12-2017-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/87d2c0d71b93/JHC-12-2017-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/ab9935d576e1/JHC-12-2017-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/9d64de8b5bbf/JHC-12-2017-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/642aef575a58/JHC-12-2017-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c4/12415389/98f0505868e3/JHC-12-2017-g0009.jpg

相似文献

1
Newly Established Anoikis-Associated Genes Predict the Prognosis of Hepatocellular Carcinoma.新建立的失巢凋亡相关基因可预测肝细胞癌的预后。
J Hepatocell Carcinoma. 2025 Sep 3;12:2017-2034. doi: 10.2147/JHC.S533398. eCollection 2025.
2
Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma.无锚定相关长非编码 RNA 特征可预测肝细胞癌的预后,并与免疫浸润相关。
Anticancer Drugs. 2024 Jun 1;35(5):466-480. doi: 10.1097/CAD.0000000000001589. Epub 2024 Mar 11.
3
The molecular sub-type and the development and validation of a prognosis prediction model based on endocytosis-related genes for hepatocellular carcinoma.基于内吞作用相关基因的肝细胞癌分子亚型及预后预测模型的构建与验证
J Gastrointest Oncol. 2025 Jun 30;16(3):1115-1126. doi: 10.21037/jgo-2025-359. Epub 2025 Jun 27.
4
A novel prognostic model based on immunogenic cell death-related genes for improved risk stratification in hepatocellular carcinoma patients.一种基于免疫原性细胞死亡相关基因的新型预后模型,用于改善肝细胞癌患者的风险分层。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10255-10267. doi: 10.1007/s00432-023-04950-5. Epub 2023 Jun 3.
5
Characterization of novel anoikis-related genes as prognostic biomarkers and key determinants of the immune microenvironment in esophageal cancer.新型失巢凋亡相关基因作为食管癌预后生物标志物及免疫微环境关键决定因素的特征分析
Front Immunol. 2025 Jul 11;16:1599171. doi: 10.3389/fimmu.2025.1599171. eCollection 2025.
6
Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.鉴定和验证与透明细胞肾细胞癌预后相关的新型凋亡相关基因特征。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11661-11678. doi: 10.1007/s00432-023-05012-6. Epub 2023 Jul 5.
7
Bioinformatics identification of key microRNA-correlated genes associated with hepatocellular carcinoma heterogeneity and prognosis.与肝细胞癌异质性和预后相关的关键微小RNA相关基因的生物信息学鉴定
BMC Gastroenterol. 2025 Jul 1;25(1):452. doi: 10.1186/s12876-025-04031-6.
8
Development and Validation of Anoiki-Related Lncrna Signature Prediction Model for KIRC Prognosis.用于肾透明细胞癌预后的anoiki相关长链非编码RNA特征预测模型的开发与验证
Comb Chem High Throughput Screen. 2025;28(9):1524-1542. doi: 10.2174/0113862073271880231114100544.
9
Identifying the predictive role and the related drugs of oxidative stress genes in the hepatocellular carcinoma.鉴定氧化应激基因在肝细胞癌中的预测作用及其相关药物。
Cancer Rep (Hoboken). 2024 Apr;7(4):e1978. doi: 10.1002/cnr2.1978.
10
Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma.基于铜死亡的肝细胞癌分子亚型和风险特征的预后和免疫意义。
Mediators Inflamm. 2023 Apr 20;2023:3951940. doi: 10.1155/2023/3951940. eCollection 2023.

本文引用的文献

1
BIRC5 as a master regulator in HCC: unraveling its role in tumor survival and therapeutic potential.BIRC5作为肝癌的主要调节因子:揭示其在肿瘤存活中的作用及治疗潜力。
Funct Integr Genomics. 2025 Jun 5;25(1):120. doi: 10.1007/s10142-025-01615-z.
2
Ginsenoside Rh1 regulates the immune microenvironment of hepatocellular carcinoma via the glucocorticoid receptor.人参皂苷Rh1通过糖皮质激素受体调节肝细胞癌的免疫微环境。
J Integr Med. 2024 Nov;22(6):709-718. doi: 10.1016/j.joim.2024.09.004. Epub 2024 Sep 30.
3
DAP3 promotes mitochondrial activity and tumour progression in hepatocellular carcinoma by regulating MT-ND5 expression.
DAP3 通过调节 MT-ND5 的表达促进肝癌中的线粒体活性和肿瘤进展。
Cell Death Dis. 2024 Jul 29;15(7):540. doi: 10.1038/s41419-024-06912-2.
4
Targeting anoikis resistance as a strategy for cancer therapy.针对失巢凋亡抵抗的癌症治疗策略。
Drug Resist Updat. 2024 Jul;75:101099. doi: 10.1016/j.drup.2024.101099. Epub 2024 Jun 1.
5
Pharmacologically inducing anoikis offers novel therapeutic opportunities in hepatocellular carcinoma.在肝细胞癌中,通过药理学诱导细胞凋亡为其提供了新的治疗机会。
Biomed Pharmacother. 2024 Jul;176:116878. doi: 10.1016/j.biopha.2024.116878. Epub 2024 Jun 5.
6
ANXA5: A Key Regulator of Immune Cell Infiltration in Hepatocellular Carcinoma.膜联蛋白 A5:调控肝癌免疫细胞浸润的关键分子。
Med Sci Monit. 2024 Jun 2;30:e943523. doi: 10.12659/MSM.943523.
7
A novel anoikis-related gene signature can predict the prognosis of hepatocarcinoma patients.一种新的失巢凋亡相关基因特征可预测肝癌患者的预后。
Transl Cancer Res. 2024 Apr 30;13(4):1834-1847. doi: 10.21037/tcr-23-2096. Epub 2024 Apr 18.
8
Comprehensive molecular classification predicted microenvironment profiles and therapy response for HCC.全面的分子分类预测了 HCC 的微环境特征和治疗反应。
Hepatology. 2024 Sep 1;80(3):536-551. doi: 10.1097/HEP.0000000000000869. Epub 2024 Mar 27.
9
Identification and verification of a prognostic autophagy-related gene signature in hepatocellular carcinoma.鉴定和验证肝细胞癌中与预后相关的自噬基因特征。
Sci Rep. 2024 Feb 6;14(1):3032. doi: 10.1038/s41598-024-53565-4.
10
Anti-stromal nanotherapeutics for hepatocellular carcinoma.抗基质纳米治疗药物用于肝细胞癌。
J Control Release. 2024 Mar;367:500-514. doi: 10.1016/j.jconrel.2024.01.050. Epub 2024 Feb 3.